Antiviral Resistance in the Genomic Era: Molecular Mechanisms, Clinical Challenges, and Pharmacogenetic Perspectives
Reviews in Medical Virology · 2026
DOI: 10.1002/rmv.70205 ↗At a glance
Übersichtsarbeit in Reviews in Medical Virology, 2026. Written by Laith Al-Eitan and 1 co-authors. Institution: Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan. Major MEDLINE topics: Drug Resistance, Viral, Antiviral Agents, Virus Diseases. 268 references.
Abstract (original language)
Antiviral treatment (ART) resistance is an emerging global phenomenon that reduces the effectiveness of antiviral therapies and raises strong challenges for public health systems. This literature review focuses on the factors that contribute to developing antiviral drug resistance and the scope of pharmacogenetics. Studies have shown that inefficient use of antiviral therapies, genetic mutations in virus strains, and a limited healthcare framework are the main factors that increase resistance rates. Specifically, the poor adherence in HIV patients, combined with the virus high mutation, are the primary driver of drug‐resistant strains development. The mutations in NS5A region reduce the efficacy of HCV direct‐acting antivirals (DAAs). Where Influenza virus resistance to neuraminidase inhibitors (NAIs) like oseltamivir has been identified in seasonal strains, most notably the H275Y mutation in H1N1. Consequently, development of these resistant strains demands multidisciplinary strategies, global coordination, effective resistance monitoring systems, and public health initiatives to overcome this phenomenon. The paper aims to present a full picture of the antiviral drug resistance, which may provide better insights for clinicians and researchers.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid, Jordan.
- Department of Medical Laboratory Science, Faculty of Applied Medical Science, Jordan University of Science and Technology, Irbid, Jordan.
ORCID profiles: Laith Al-Eitan, Rania Al-Samama'h
Cite
APA
Al-Eitan, L., & Al-Samama'h, R. (2026). Antiviral Resistance in the Genomic Era: Molecular Mechanisms, Clinical Challenges, and Pharmacogenetic Perspectives. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70205
Vancouver
Al-Eitan L, Al-Samama'h R. Antiviral Resistance in the Genomic Era: Molecular Mechanisms, Clinical Challenges, and Pharmacogenetic Perspectives. Reviews in Medical Virology. 2026. doi:10.1002/rmv.70205
BibTeX
@article{AlEitan2026,
author = {Al-Eitan, Laith and Al-Samama'h, Rania},
title = {Antiviral Resistance in the Genomic Era: Molecular Mechanisms, Clinical Challenges, and Pharmacogenetic Perspectives},
journal = {Reviews in Medical Virology},
year = {2026},
doi = {10.1002/rmv.70205}
}
EUVIMED